DocDollars

Trillium Therapeutics USA, LLC

MA · United States · Reporting entity ID 100001171894

Total reported 2019–2025
$9.71M
#497 of 2,960 reporting companies — 0% of all reported industry payments
$8K in general payments across 8 records, plus $9.70M in research funding across 1,095 records.

How it breaks down

General payments $7,951
Research funding $9,704,459

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Trillium Therapeutics USA, LLC reported $9.71M to US doctors and teaching hospitals from 2019 to 2025, ranking #497 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 8 general payment records and 1,095 research records were filed.

Common questions about Trillium Therapeutics USA, LLC

How much has Trillium Therapeutics USA, LLC paid US doctors?

Trillium Therapeutics USA, LLC reported $9,712,410 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $7,951 in general payments, $9,704,459 in research funding.

How does Trillium Therapeutics USA, LLC rank among drug and device companies?

It ranks #497 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Trillium Therapeutics USA, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.